cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.13019414.v1
title: Construct-concurrent validity and reliability of the European Child Environment Questionnaire (ECEQ) in a sample of Turkish children with cerebral palsy

description: To investigate the construct-concurrent validity and reliability of the Turkish version of the European Child Environment Questionnaire (ECEQ-T) in children with cerebral palsy (CP). Mean age 9.53 ± 4.45 years 306 children with CP and their parents participated in the study. While construct validity was assessed using confirmatory factor analysis, concurrent validity was investigated using the correlation between ECEQ-T and Pediatric Evaluation of Disability Inventory (PEDI) with Spearman’s correlation analysis. For test–retest reliability, ECEQ-T was administered twice to 65 parents with an interval of two weeks. Cronbach’s alpha (<i>α</i>) and Intraclass Correlation Coefficient (ICC) were used for reliability. Construct validity (RMSEA &gt; 0.080; GFI ≥ 0.90) and concurrent validity (<i>r</i>: −0.533 to −0.293; <i>p</i> α and ICC values were found (Cronbach <i>α</i><sub>PE</sub>: 0.960/ICC<sub>PE</sub>: 0.959, Cronbach <i>α</i><sub>SS</sub>: 0.955/ICC<sub>SS</sub>: 0.954), Cronbach <i>α</i><sub>A</sub>: 0.822/ICC<sub>A</sub>: 0.802, Cronbach <i>α</i><sub>T</sub>: 0.957/ICC<sub>T</sub>: 0.955). ECEQ-T has demonstrated good psychometric properties and can be used as a reliable and valid measure to assess environmental factors. We believe that ECEQ-T is a useful and detailed questionnaire to determine barriers-facilitators for increasing activity and participation in Turkish children with CP.IMPLICATIONS FOR REHABILITATIONThe Turkish version of ECEQ has acceptable construct validity and moderate concurrent validity for evaluating environmental factors in children with cerebral palsy.The Turkish version of ECEQ provides valuable information, which could be helpful to guide public health services and government policies in order to optimize the participation of children with CP.Environmental factors may play an important role in activity and participation in children with cerebral palsy. Turkish version of the ECEQ can be used for evaluating the environmental factors to determine barriers of activity and participation. The Turkish version of ECEQ has acceptable construct validity and moderate concurrent validity for evaluating environmental factors in children with cerebral palsy. The Turkish version of ECEQ provides valuable information, which could be helpful to guide public health services and government policies in order to optimize the participation of children with CP. Environmental factors may play an important role in activity and participation in children with cerebral palsy. Turkish version of the ECEQ can be used for evaluating the environmental factors to determine barriers of activity and participation.
DOI: 10.6084/m9.figshare.12888567.v1
title: Canes may not improve spatiotemporal parameters of walking after stroke: a systematic review of cross-sectional within-group experimental studies

description: To examine whether using a cane would improve spatiotemporal parameters of walking, i.e., speed, stride length, cadence, and symmetry after stroke. Searches were conducted in eight databases. The experimental condition was walking with a cane. Four outcomes were of interest: walking speed, stride length, cadence, and symmetry. Twelve studies were included. Results from nine studies suggested that individuals with stroke walked 0.01 m/s (SD 0.06) slower with a single-point cane, compared with no cane. Two studies suggested a reduction in cadence (MD-5 steps/min, SD2) and an increase in stride length (MD 0.08 m, SD 0.01). Three studies suggested that individuals walked 0.06 m/s (SD 0.07) slower with a four-point cane, compared with no cane. Four studies suggested that individuals walked 0.06 m/s (SD 0.04) faster with a single- point cane compared with a four-point cane. Results regarding other outcomes were inconclusive. Results showed no worthwhile improvements in spatiotemporal parameters of walking with a single-point cane and a slight reduction with a four-point cane, compared with no cane. Individuals walked slightly faster with a single-point cane compared with a four-point cane, but the evidence is insufficient to support this superiority.IMPLICATIONS FOR REHABILITATIONA single-point cane may not improve spatiotemporal parameters of walking after stroke.Walking with a four-point cane may slightly decrease spatiotemporal parameters of walking.Canes may be prescribed without the fear of negatively impairing walking kinematics. A single-point cane may not improve spatiotemporal parameters of walking after stroke. Walking with a four-point cane may slightly decrease spatiotemporal parameters of walking. Canes may be prescribed without the fear of negatively impairing walking kinematics.
DOI: 10.6084/m9.figshare.12949260.v1
title: Effectiveness of manual therapy in patients with tension-type headache. A systematic review and meta-analysis

description: To systematically review the evidence about the effectiveness of manual therapy (MT) on pain intensity, frequency and impact of headache in individuals with tension-type headache (TTH). Medline, Embase, Scopus, Web of Science, CENTRAL, and PEDro were searched in June 2020. Randomized controlled trials that applied MT not associated with other interventions for TTH were selected. The level of evidence was synthesized using GRADE, and Standardized Mean Differences (SMD) were calculated for meta-analysis. Fifteen studies were included with a total sample of 1131 individuals. High velocity and low amplitude techniques were not superior to no treatment on reducing pain intensity (SMD = 0.01, low evidence) and frequency (SMD = −0.27, moderate evidence). Soft tissue interventions were superior to no treatment on reducing pain intensity (SMD = −0.86, low evidence) and frequency of pain (SMD = −1.45, low evidence). Dry needling was superior to no treatment on reducing pain intensity (SMD = −5.16, moderate evidence) and frequency (SMD = −2.14, moderate evidence). Soft tissue interventions were not superior to no treatment and other treatments on the impact of headache. Manual therapy may have positive effects on pain intensity and frequency, but more studies are necessary to strengthen the evidence of the effects of manual therapy on subjects with tension-type headache.Implications for rehabilitationSoft tissue interventions and dry needling can be used to improve pain intensity and frequency in patients with tension type headache.High velocity and low amplitude thrust manipulations were not effective for improving pain intensity and frequency in patients with tension type headache.Manual therapy was not effective for improving the impact of headache in patients with tension type headache. Soft tissue interventions and dry needling can be used to improve pain intensity and frequency in patients with tension type headache. High velocity and low amplitude thrust manipulations were not effective for improving pain intensity and frequency in patients with tension type headache. Manual therapy was not effective for improving the impact of headache in patients with tension type headache.
DOI: 10.6084/m9.figshare.12888567
title: Canes may not improve spatiotemporal parameters of walking after stroke: a systematic review of cross-sectional within-group experimental studies

description: To examine whether using a cane would improve spatiotemporal parameters of walking, i.e., speed, stride length, cadence, and symmetry after stroke. Searches were conducted in eight databases. The experimental condition was walking with a cane. Four outcomes were of interest: walking speed, stride length, cadence, and symmetry. Twelve studies were included. Results from nine studies suggested that individuals with stroke walked 0.01 m/s (SD 0.06) slower with a single-point cane, compared with no cane. Two studies suggested a reduction in cadence (MD-5 steps/min, SD2) and an increase in stride length (MD 0.08 m, SD 0.01). Three studies suggested that individuals walked 0.06 m/s (SD 0.07) slower with a four-point cane, compared with no cane. Four studies suggested that individuals walked 0.06 m/s (SD 0.04) faster with a single- point cane compared with a four-point cane. Results regarding other outcomes were inconclusive. Results showed no worthwhile improvements in spatiotemporal parameters of walking with a single-point cane and a slight reduction with a four-point cane, compared with no cane. Individuals walked slightly faster with a single-point cane compared with a four-point cane, but the evidence is insufficient to support this superiority.IMPLICATIONS FOR REHABILITATIONA single-point cane may not improve spatiotemporal parameters of walking after stroke.Walking with a four-point cane may slightly decrease spatiotemporal parameters of walking.Canes may be prescribed without the fear of negatively impairing walking kinematics. A single-point cane may not improve spatiotemporal parameters of walking after stroke. Walking with a four-point cane may slightly decrease spatiotemporal parameters of walking. Canes may be prescribed without the fear of negatively impairing walking kinematics.
DOI: 10.6084/m9.figshare.12910145
title: The development of a consensus statement for the prescription of powered wheelchair standing devices in Duchenne muscular dystrophy

description: To develop a consensus statement for the prescription of a Powered Wheelchair Standing Device (PWSD) in young people with Duchenne muscular dystrophy (DMD). An international multidisciplinary panel comprising clinicians and users (young people with DMD) along with their parents was consulted. A literature review was undertaken and a Delphi method was utilised to generate consensus statements. To supplement limited literature, round one of the Delphi process comprised questions consistent with the International Classification of Functioning, Disability and Health model of disability to generate items based on expert opinion and was completed by 38 clinicians and nine users. Thirty-seven participants completed two further rounds rating the importance of each item with a five-point scale. Agreement of 70% or more participants for items indicated consensus. Consensus was reached for 47 of 80 items. Tolerance and comfort in supported standing for at least 10 min, ankle contracture less than 10 degrees and user goals reflecting motivation to use the standing function were agreed as necessary in guiding the decision to trial a PWSD. Evidence of family, therapist and servicing support were also considered critical in enabling continuity of PWSD use. PWSD is a mobility option that offers choice, control and opportunity for independence. This consensus statement can assist clinicians with decision-making around factors influencing successful implementation and optimisation of PWSD for young people with DMD.Implications for RehabilitationTolerance and comfort in supported standing for at least 10 minutes, ankle contracture limited to less than 10 degrees and the child’s goals reflecting motivation to use the standing position were agreed to be necessary considerations in guiding the decision to trial a PWSD.Trialling a PWSD when the child is predicted to lose the ability to walk within a one to two year period was recommended although a PWSD could be suitable for a child who was unable to walk.Evidence of family, therapist and servicing support was considered critical in enabling continuity of PWSD use. Tolerance and comfort in supported standing for at least 10 minutes, ankle contracture limited to less than 10 degrees and the child’s goals reflecting motivation to use the standing position were agreed to be necessary considerations in guiding the decision to trial a PWSD. Trialling a PWSD when the child is predicted to lose the ability to walk within a one to two year period was recommended although a PWSD could be suitable for a child who was unable to walk. Evidence of family, therapist and servicing support was considered critical in enabling continuity of PWSD use.
DOI: 10.6084/m9.figshare.12910145.v1
title: The development of a consensus statement for the prescription of powered wheelchair standing devices in Duchenne muscular dystrophy

description: To develop a consensus statement for the prescription of a Powered Wheelchair Standing Device (PWSD) in young people with Duchenne muscular dystrophy (DMD). An international multidisciplinary panel comprising clinicians and users (young people with DMD) along with their parents was consulted. A literature review was undertaken and a Delphi method was utilised to generate consensus statements. To supplement limited literature, round one of the Delphi process comprised questions consistent with the International Classification of Functioning, Disability and Health model of disability to generate items based on expert opinion and was completed by 38 clinicians and nine users. Thirty-seven participants completed two further rounds rating the importance of each item with a five-point scale. Agreement of 70% or more participants for items indicated consensus. Consensus was reached for 47 of 80 items. Tolerance and comfort in supported standing for at least 10 min, ankle contracture less than 10 degrees and user goals reflecting motivation to use the standing function were agreed as necessary in guiding the decision to trial a PWSD. Evidence of family, therapist and servicing support were also considered critical in enabling continuity of PWSD use. PWSD is a mobility option that offers choice, control and opportunity for independence. This consensus statement can assist clinicians with decision-making around factors influencing successful implementation and optimisation of PWSD for young people with DMD.Implications for RehabilitationTolerance and comfort in supported standing for at least 10 minutes, ankle contracture limited to less than 10 degrees and the child’s goals reflecting motivation to use the standing position were agreed to be necessary considerations in guiding the decision to trial a PWSD.Trialling a PWSD when the child is predicted to lose the ability to walk within a one to two year period was recommended although a PWSD could be suitable for a child who was unable to walk.Evidence of family, therapist and servicing support was considered critical in enabling continuity of PWSD use. Tolerance and comfort in supported standing for at least 10 minutes, ankle contracture limited to less than 10 degrees and the child’s goals reflecting motivation to use the standing position were agreed to be necessary considerations in guiding the decision to trial a PWSD. Trialling a PWSD when the child is predicted to lose the ability to walk within a one to two year period was recommended although a PWSD could be suitable for a child who was unable to walk. Evidence of family, therapist and servicing support was considered critical in enabling continuity of PWSD use.
DOI: 10.21942/uva.19732993
title: ALeaseBert

description: <strong>DATA</strong> This is the data from the paper "A Benchmark for Lease Contract Review" (https://arxiv.org/abs/2010.10386). The weights of our ALeaseBERT model (ALeaseBert.zip) The dataset of lease contracts and its annotations (annotated_dataset.zip) Samples: sample.html is a contract, sample.json has the corresponding annotations Metadata: annotations-legend.json has the dictionary of annotated entities <br> <strong>LICENSE</strong> This data is made available under the terms of <strong>CC BY-NC 4.0 </strong> <br> See http://creativecommons.org/licenses/by-nc/4.0/deed.en See http://creativecommons.org/licenses/by-nc/4.0/legalcode <br> <br>
DOI: 10.21942/uva.19732993.v1
title: ALeaseBert

description: <strong>DATA</strong> This is the data from the paper "A Benchmark for Lease Contract Review" (https://arxiv.org/abs/2010.10386). The weights of our ALeaseBERT model (ALeaseBert.zip) The dataset of lease contracts and its annotations (annotated_dataset.zip) Samples: sample.html is a contract, sample.json has the corresponding annotations Metadata: annotations-legend.json has the dictionary of annotated entities <br> <strong>LICENSE</strong> This data is made available under the terms of <strong>CC BY-NC 4.0 </strong> <br> See http://creativecommons.org/licenses/by-nc/4.0/deed.en See http://creativecommons.org/licenses/by-nc/4.0/legalcode <br> <br>
DOI: 10.6084/m9.figshare.19933025
title: Additional file 1 of Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

description: Additional file 1: Table S1. Clinical characteristics of the MPM samples that underwent whole genome sequencing
DOI: 10.6084/m9.figshare.19933025.v1
title: Additional file 1 of Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

description: Additional file 1: Table S1. Clinical characteristics of the MPM samples that underwent whole genome sequencing
DOI: 10.6084/m9.figshare.19933031
title: Additional file 3 of Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

description: Additional file 3: Table S2. Summary of read depth and the number of somatic mutations identified in MPM samples from whole genome sequencing.
DOI: 10.6084/m9.figshare.19933031.v1
title: Additional file 3 of Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

description: Additional file 3: Table S2. Summary of read depth and the number of somatic mutations identified in MPM samples from whole genome sequencing.
DOI: 10.6084/m9.figshare.19933034.v1
title: Additional file 4 of Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

description: Additional file 4: Table S3. Somatic coding mutations detected in the 58 MPM.
DOI: 10.6084/m9.figshare.19933040
title: Additional file 5 of Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

description: Additional file 5: Table S4. Somatic structural rearrangements detected in the 58 MPM samples.
DOI: 10.6084/m9.figshare.19933034
title: Additional file 4 of Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

description: Additional file 4: Table S3. Somatic coding mutations detected in the 58 MPM.
DOI: 10.6084/m9.figshare.19933043
title: Additional file 6 of Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

description: Additional file 6: Table S5. Significantly mutated gene analysis in MPM.
DOI: 10.6084/m9.figshare.19933040.v1
title: Additional file 5 of Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

description: Additional file 5: Table S4. Somatic structural rearrangements detected in the 58 MPM samples.
DOI: 10.6084/m9.figshare.19933043.v1
title: Additional file 6 of Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

description: Additional file 6: Table S5. Significantly mutated gene analysis in MPM.
DOI: 10.6084/m9.figshare.19933059
title: Additional file 3 of Colorectal cancer concurrent gene signature based on coherent patterns between genomic and transcriptional alterations

description: Additional file 3.
DOI: 10.6084/m9.figshare.19933059.v1
title: Additional file 3 of Colorectal cancer concurrent gene signature based on coherent patterns between genomic and transcriptional alterations

description: Additional file 3.
DOI: 10.6084/m9.figshare.19933079
title: Additional file 1 of Gut microbiome mediates the protective effects of exercise after myocardial infarction

description: Additional file 1: Table S1. Data production of 49 samples in Sham+Control, MI+Control, Sham+Run, and MI+Run. Table S2. Alpha Diversity index among Sham+Control, MI+Control, Sham+Run, and MI+Run. Table S3. The difference of Alpha Diversity index among Sham+Control, MI+Control, Sham+Run, and MI+Run. Table S4. Relative abundance profile at the phylum level among Sham+Control, MI+Control, Sham+Run, and MI+Run. Table S5. Relative abundance profile at the genus level among Sham+Control, MI+Control, Sham+Run, and MI+Run. Table S6. Detailed information of genera differently enriched across Sham+Control and MI+Control. Table S7. Detailed information of genera differently enriched across MI+Control and MI+Run. Table S8. Alpha Diversity index among MI+ABX, MI+ABX+Control, MI+1/4ABX+Control and MI+Untreated+Control. Table S9. The difference of Alpha Diversity index among MI+ABX, MI+ABX+Control, MI+1/4ABX+Control and MI+Untreated+Control. Table S10. Alpha Diversity index among MI+ABX+Run, MI+1/4ABX+Run and MI+Untreated+Run. Table S11. The difference of Alpha Diversity index among MI+ABX+Run, MI+1/4ABX+Run and MI+Untreated+Run. Table S12. Relative abundance profile at the phylum level among MI+ABX, MI+ABX+Control, MI+1/4ABX+Control and MI+Untreated+Control. Table S13. Relative abundance profile at the phylum level among MI+ABX+Run, MI+1/4ABX+Run and MI+Untreated+Run. Table S14. Detailed information of genera differently enriched across MI+ABX+Run, MI+1/4ABX+Run and MI+Untreated+Run. Table S15. Relative abundance profile at the phylum level among MI+ABX+PBS, MI+ABX+FMT(MI+Control) and MI+ABX+FMT(MI+Run). Table S16. Relative abundance profile at the genus level among MI+ABX+PBS, MI+ABX+FMT(MI+Control) and MI+ABX+FMT(MI+Run). Table S17. Quantitative data of 116 metabolites in Sham+Control, MI+Control, Sham+Run, and MI+Run. Table S18. The relative abundance of each metabolite classes in Sham+Control, MI+Control, Sham+Run, and MI+Run. Table S19. Detailed information of Univariate Statistics across Sham+Control and MI+Control. Table S20..Detailed information of Univariate Statistics across Sham+Control and Sham+RUN. Table S21. Detailed information of 42 metabolites differently enriched across Sham+Control and MI+Control. Table S22. Detailed information of 37 metabolites differently enriched across MI+Control and MI+Run. Table S23. Detailed information of metabolites pathways analysis across MI+Control and MI+Run. Table S24. Detailed information of metabolites pathways on network across MI+Control and MI+Run. Table S25. Detailed information of pathways analysis across Sham+Control and MI+Control. Table S26. Detailed information of metabolites metabolites pathways on network across Sham+Control and MI+Control. Table S27. Detailed information of pathways analysis across Sham+Control and Sham+Run. Table S28. Detailed information of metabolites metabolites pathways on network across Sham+Control and Sham+Run. Table S29. Detailed information of the relationship between metabolites and the top 50 genera